parkinson's disease - Search News

Black Sabbath to reunite amid frontman's Parkinson's disease

Hosted on MSN · 4h

Ozzy Osbourne's Parkinson's disease 'affected his legs,' Sharon says as his last show looms

Heavy metal star Ozzy Osbourne reveals the date for his final show, which will also reunite the founding members of Black Sabbath after 20 years.

USA TODAY on MSN · 8h

Ozzy Osbourne's final show: Black Sabbath to reunite amid frontman's Parkinson's disease

Ozzy Osbourne will come out of touring retirement and reunite with the full Black Sabbath lineup for the first time in 20 years.

US Weekly on MSN · 22h

Ozzy Osbourne Says He Can No Longer Walk Amid Battle With Parkinson’s Disease

Sharon Osbourne shared an update on Ozzy Osbourne’s battle with Parkinson’s disease before his final show with Black Sabbat

Daniel Barenboim, Parkinson's disease

The Washington Post · 1d

Conductor Daniel Barenboim says he's been diagnosed with Parkinson's disease

Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday on Instagram. He has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner’s Ring Cycle in Berlin.

The New York Times · 1d

Daniel Barenboim Announces He Has Parkinson’s Disease

Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, said Thursday that he has Parkinson’s disease.

BBC on MSN · 1d

Conductor Barenboim reveals Parkinson's diagnosis

The renowned musician says he plans to keep playing, after confirming the long-suspected diagnosis.

Despite Early Promise GLP-1 Disappoints in Parkinson’s Disease

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

1d

FDA approves wearable infusion device for advanced Parkinson disease

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

Study Finds Exenatide Not Beneficial for Parkinson Disease

The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease seve ...

FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease

Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...

GLP-1 does not slow Parkinson’s disease progression in phase 3 study

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

A breakthrough in Parkinson’s disease detection

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

9don MSN

Can mold exposure cause Parkinson’s disease? Colorado Springs family hopes to prove “landmark” legal case

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...

2d

Drug Similar to Ozempic Failed to Treat Parkinson’s Disease in a Trial

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results